Gilewski T - Search Results

1

Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy.

Hudis C, Seidman A, Baselga J, Raptis G, Lebwohl D, Gilewski T, Moynahan M, Sklarin N, Fennelly D, Crown JP, Surbone A, Uhlenhopp M, Riedel E, Yao TJ, Norton L. Hudis C, et al. Among authors: gilewski t. J Clin Oncol. 1999 Jan;17(1):93-100. doi: 10.1200/JCO.1999.17.1.93. J Clin Oncol. 1999. PMID: 10458222 Clinical Trial.

2

Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer.

Drullinsky P, Sugarman SM, Fornier MN, D'Andrea G, Gilewski T, Lake D, Traina T, Wasserheit-Lieblich C, Sklarin N, Atieh-Graham D, Mills N, Troso-Sandoval T, Seidman AD, Yuan J, Patel H, Patil S, Norton L, Hudis C. Drullinsky P, et al. Among authors: gilewski t. Clin Breast Cancer. 2010 Dec 1;10(6):440-4. doi: 10.3816/CBC.2010.n.057. Clin Breast Cancer. 2010. PMID: 21147686 Free PMC article. Clinical Trial.

3

Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, et al. Seidman AD, et al. Among authors: gilewski ta. J Natl Cancer Inst Monogr. 1993;(15):171-5. J Natl Cancer Inst Monogr. 1993. PMID: 7517153

4

Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer.

Seidman AD, Norton L, Reichman BS, Crown JP, Yao TJ, Hakes TB, Lebwohl DE, Gilewski TA, Hudis CA, Surbone A, et al. Seidman AD, et al. Among authors: gilewski ta. Oncology. 1994 Oct;51 Suppl 1:33-9. doi: 10.1159/000227414. Oncology. 1994. PMID: 7526308 Clinical Trial.

5

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Currie V, Hakes TB, Hudis CA, Gilewski TA, Baselga J, Forsythe P, et al. Seidman AD, et al. Among authors: gilewski ta. J Clin Oncol. 1995 May;13(5):1152-9. doi: 10.1200/JCO.1995.13.5.1152. J Clin Oncol. 1995. PMID: 7537798 Clinical Trial.

6

Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer.

Seidman AD, Norton L, Reichman BS, Crown JP, Yao TJ, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, et al. Seidman AD, et al. Among authors: gilewski ta. Semin Oncol. 1993 Aug;20(4 Suppl 3):40-5. Semin Oncol. 1993. PMID: 7688145 Clinical Trial.

7

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.

Reichman BS, Seidman AD, Crown JP, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, Hudis CA, et al. Reichman BS, et al. Among authors: gilewski ta. J Clin Oncol. 1993 Oct;11(10):1943-51. doi: 10.1200/JCO.1993.11.10.1943. J Clin Oncol. 1993. PMID: 7691998 Clinical Trial.

8

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.

Hudis CA, Seidman AD, Crown JP, Balmaceda C, Freilich R, Gilewski TA, Hakes TB, Currie V, Lebwohl DE, Baselga J, Raptis G, Gollub M, Robles M, Bruno R, Norton L. Hudis CA, et al. Among authors: gilewski ta. J Clin Oncol. 1996 Jan;14(1):58-65. doi: 10.1200/JCO.1996.14.1.58. J Clin Oncol. 1996. PMID: 8558221 Clinical Trial.

9

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.

Seidman AD, Hochhauser D, Gollub M, Edelman B, Yao TJ, Hudis CA, Francis P, Fennelly D, Gilewski TA, Moynahan ME, Currie V, Baselga J, Tong W, O'Donaghue M, Salvaggio R, Auguste L, Spriggs D, Norton L. Seidman AD, et al. Among authors: gilewski ta. J Clin Oncol. 1996 Jun;14(6):1877-84. doi: 10.1200/JCO.1996.14.6.1877. J Clin Oncol. 1996. PMID: 8656256 Clinical Trial.

10

Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.

Barakat RR, Gilewski TA, Almadrones L, Saigo PE, Venkatraman E, Hudis C, Hoskins WJ. Barakat RR, et al. Among authors: gilewski ta. J Clin Oncol. 2000 Oct 15;18(20):3459-63. doi: 10.1200/JCO.2000.18.20.3459. J Clin Oncol. 2000. PMID: 11032585 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page